$10.500
0.000 (0.00%)At close
ACVA News
ACVA Events
Copart Completes Acquisition of ACV Auctions
Copart (CPRT) announced the completion of its acquisition of ACV Auctions (ACVA). Copart completed the cash tender offer, through its wholly owned subsidiary Apple Merger Sub, to acquire all of the issued and outstanding shares of common stock of ACV at a purchase price of $10.50 per share, net to the seller in cash, without interest, subject to any applicable withholding taxes. As of the tender offer expiration at 5:00 p.m., Eastern Time, on October 15, 116,818,409 shares of ACV common stock were validly tendered, representing approximately 68.43% of the total number of ACV's issued and outstanding shares of common stock as of such date and time. All such shares have been accepted for payment in accordance with the terms of the tender offer, and Copart, on behalf of Purchaser, will promptly pay for such shares. Following the completion of the tender offer, Copart completed the acquisition of ACV through the merger of Purchaser with ACV. As a result of the merger, each share of ACV common stock issued and outstanding and not tendered in the tender offer was cancelled and converted into the right to receive the same $10.50 per share in cash, without interest, subject to any applicable withholding taxes, paid in the tender offer. With the completion of the acquisition, shares of ACV common stock have ceased trading on the New York Stock Exchange and ACV will now operate as an independent subsidiary of Copart led by ACV's existing leadership team.
Copart's Antitrust Waiting Period for ACV Auctions Acquisition Expired
Copart (CPRT) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, the "HSR Act," in connection with Copart's pending acquisition of ACV Auctions (ACVA) expired at 11:59 p.m., Eastern Time, on October 13, 2026.
Copart Extends ACV Auctions Tender Offer Deadline to October 15, 2026
Copart (CPRT) announced that its wholly owned subsidiary Apple Merger Sub has further extended the expiration date of its all-cash tender offer to purchase all of the issued and outstanding shares of common stock, par value $0.001 per share, of ACV Auctions (ACVA), at a price of $10.50 per Share, net to the seller in cash, without interest, subject to any applicable withholding taxes. The tender offer, which was previously extended and scheduled to expire at 5:00 p.m., Eastern Time, on October 7, 2026, has been further extended and will now expire at 5:00 p.m., Eastern Time, on October 15, 2026, unless further extended or earlier terminated
Copart Extends Cash Tender Offer for ACV Auctions to $10.50
Copart (CPRT) announced that its wholly owned subsidiary Apple Merger Sub has extended the expiration date of its all-cash tender offer to purchase all of the issued and outstanding shares of common stock, par value $0.001 per share, of ACV Auctions (ACVA), at a price of $10.50 per Share, net to the seller in cash, without interest, subject to any applicable withholding taxes. The tender offer, which was previously scheduled to expire at one minute following 11:59 p.m., Eastern Time, on September 30, has been extended to 5:00 p.m., Eastern Time, on October 7. On September 29, Copart disclosed that it had withdrawn and refiled its Premerger Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in order to provide the Antitrust Division of the Department of Justice and the Federal Trade Commission with additional time to complete their review of the transaction. Copart refiled its Premerger Notification and Report Form on September 28. The waiting period under the HSR Act expires at 11:59 p.m., Eastern Time, on October 13, but this period may be terminated earlier if the agencies exercise their discretion to grant early termination.
Northcoast Downgrades ACV Auctions to Neutral
Northcoast downgraded ACV Auctions (ACVA) to Neutral from Buy after the company agreed to be acquired by Copart (CPRT) for $10.50 per share in cash.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.









